Guilherme Dagostin de Carvalho

Guilherme Dagostin de Carvalho

Auto-generated profile, based on publicly available information

Guilherme Dagostin de Carvalho

Instituto Dante Pazzanese de Cardiologia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
RSRicardo F. O. Suruagy‐Motta
Ricardo F. O. Suruagy‐Motta
CFChristian K. Fukunaga
Christian K. Fukunaga
ESEverton V. B. da Silva
Everton V. B. da Silva
GNGabriel R. Neves
Gabriel R. Neves
KSKarlos D. A. dos Santos
Karlos D. A. dos Santos
GCGuilherme D. de Carvalho
Guilherme D. de Carvalho

19 January 2022 in Journal of Cardiology Cases
Verified
Journal Article
Closed access
CLCarolina Isabel Silva Lemes
Carolina Isabel Silva Lemes
LALuciana Vidal Armaganijan
Luciana Vidal Armaganijan
AMAndré Soares Maria
André Soares Maria
GCGuilherme Dagostin de Carvalho
Guilherme Dagostin de Carvalho
MMMarcel Pereira Moussa
Marcel Pereira Moussa
CDCristiano Oliveira Dietrich
Cristiano Oliveira Dietrich

1 January 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
GCGuilherme Dagostin de Carvalho
Guilherme Dagostin de Carvalho
LALuciana Vidal Armaganijan
Luciana Vidal Armaganijan
RLRenato Delascio Lopes
Renato Delascio Lopes
MOMárcia Olandoski
Márcia Olandoski
BGBeatriz Millions Do Amaral Galvão
Beatriz Millions Do Amaral Galvão
DMDalmo Antônio Ribeiro Moreira
Dalmo Antônio Ribeiro Moreira
OBJECTIVE: Risk stratification of sudden cardiac death in patients with coronary artery disease is of great importance. We evaluated the association between ventricular repolarization and induction of malignant ventricular arrhythmias on electrophysiological study of patients with coronary artery disease. METHODS AND RESULTS: A total of 177 patients (65 +/- 10.1 years, 83.6% male, mean left ventricular ejection fraction [LVEF] 37.5 +/- 13.6%) were analyzed. For each 10 ms increment in the QT interval, there was a 7% increase in malignant ventricular arrhythmias inducibility; QT cutoff point of 452 ms had an accuracy of 0.611 for predicting malignant ventricular arrhythmias (p=0.011). Male gender (odds ratio [OR]=4.18, p=0.012), LVEF 35% (OR=2.32, p=0.013), amiodarone use (OR=2.01, p=0.038), and prolonged QT (OR=1.07, p=0.023) were associated with malignant ventricular arrhythmias. In patients with ventricular dysfunction, QT 452 ms was associated with significantly increased risk of malignant ventricular arrhythmias (OR=5.44, p=0.0004). In those with LVEF 335%, QT dispersion (QTd) was significantly higher in patients with inducible malignant ventricular arrhythmias. QTd >20 ms had 0.638 accuracy and 81.3% negative predictive value in predicting malignant ventricular arrhythmias. CONCLUSION: QT interval is an independent factor associated with malignant ventricular arrhythmias in patients with coronary artery disease. The combination of ventricular dysfunction and prolonged QT interval is associated with a 5.44-fold increase of malignant ventricular arrhythmias induction. Male gender, amiodarone use, and decreased left ventricular ejection fraction are also associated with increased risk of inducibility of malignant ventricular arrhythmias on the electrophysiological study.

27 July 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
BEBruna Olandoski Erbano
Bruna Olandoski Erbano
NSNicolle Amboni Schio
Nicolle Amboni Schio
RLRenato Delascio Lopes
Renato Delascio Lopes
TBTiago Costa Bignoto
Tiago Costa Bignoto
MOMarcia Olandoski
Marcia Olandoski
DSDimytri Alexandre de Alvim Siqueira
Dimytri Alexandre de Alvim Siqueira
The extent of cardiac damage associated with aortic stenosis has important prognostic implications after transcatheter aortic valve replacement (TAVR). However, the role of tricuspid regurgitation (TR) in this clinical setting is still unclear. To explore the association between TR and mortality in patients undergoing TAVR and assess changes in TR severity post TAVR and its relationship with short and mid-term mortality. Relevant databases were searched for articles published from inception until August 2020. Out of 414 screened studies, we selected 24 that reported the degree of TR pre or post TAVR. The primary outcome was all-cause mortality, and random effects meta-analysis models were conducted (at a significance level of 5%). Seventeen studies reported associations between pre-TAVR TR and all-cause mortality (> 45,000 participants) and thirteen accessed TR severity post TAVR (709 participants). Moderate/severe baseline TR was associated to higher all-cause mortality both at 30 days (HR 1.65; 95% CI, 1.20-2.29) and 1.2 years (HR 1.56; 95% CI, 1.31-1.84). After TAVR, 43% of patients presented a decrease of at least one grade in TR (30 days, 95% CI, 30-56%), sustained at 12.5 months in 44% of participants (95% CI, 35-52%). Persistence of significant TR was associated with a two-fold increase in all-cause mortality (HR 2.12; 95% CI, 1.53-2.92). Significant TR pre TAVR is associated with higher mortality. Although TR severity may improve, the persistence of significant TR post TAVR is strongly associated with increased mortality. Our findings highlight the importance of a detailed assessment of TR pre and post TAVR and might help identify patients who may benefit from more careful surveillance in this scenario.

1 January 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
José Nunes de AlencarJosé Nunes de Alencar
José Nunes de Alencar
FRFabio Mahamad Rassi
Fabio Mahamad Rassi
RRRaquel Pereira Rios
Raquel Pereira Rios
MSMatheus Kiszka Scheffer
Matheus Kiszka Scheffer
GCGuilherme Dagostin de Carvalho
Guilherme Dagostin de Carvalho
Background Wolff-Parkinson-White (WPW) syndrome is characterized by ventricular pre-excitation, which can lead to severe arrhythmic events such as supraventricular tachycardia and pre-excited atrial fibrillation. The diagnostic value of non-invasive exercise tests in detecting high-risk accessory pathways remains inconsistent in the literature. Objectives To evaluate the diagnostic accuracy of non-invasive exercise tests compared to invasive electrophysiological studies (EPS) for identifying high-risk accessory pathways in WPW syndrome. Methods Following PRISMA-DTA guidelines, a comprehensive search was conducted in PubMed, Scopus, and Web of Science databases. Eligible studies assessed the sensitivity, specificity, and likelihood ratios of non-invasive exercise tests in WPW patients, using EPS as the reference standard. A bivariate random-effects model was applied for meta-analysis. Results Six studies, comprising a total of 765 patients, met the inclusion criteria. The pooled sensitivity was 92.7% (95% CI: 88.0% – 94.0%), while the pooled specificity was 28.1% (95% CI: 23% – 35.1%). A negative likelihood ratio (LR-) of 0.260 (95% CI: 0.174 – 0.387) indicated that the presence of a high-risk accessory pathway is about four times less likely after a negative test result. Sensitivity analysis restricted to pediatric patients showed consistent results. Conclusion Non-invasive exercise tests demonstrate a reasonable diagnostic utility for ruling out high-risk pathways in WPW syndrome. However, caution is advised when using these tests as standalone criteria for risk stratification.

13 October 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
NBNelson Barrera
Nelson Barrera
YKYevhen Kushnir
Yevhen Kushnir
MSMaria Solorzano
Maria Solorzano
FGFrancisco Gallegos‐Koyner
Francisco Gallegos‐Koyner
PLPatrick T. Lynch
Patrick T. Lynch
ADAndre D’Avila
Andre D’Avila